HeartBeam Inc. (BEAT)
| Bid | 1.65 |
| Market Cap | 58.68M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -19.45M |
| EPS (ttm) | -0.73 |
| PE Ratio (ttm) | -2.38 |
| Forward PE | -2.36 |
| Analyst | Hold |
| Ask | 2.07 |
| Volume | 47,515 |
| Avg. Volume (20D) | 78,480 |
| Open | 1.78 |
| Previous Close | 1.75 |
| Day's Range | 1.72 - 1.78 |
| 52-Week Range | 1.45 - 3.48 |
| Beta | -0.60 |
About BEAT
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the...
Analyst Forecast
According to 1 analyst ratings, the average rating for BEAT stock is "Hold." The 12-month stock price forecast is $8, which is an increase of 359.77% from the latest price.
Stock Forecasts
2 months ago · businesswire.com
HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common StockSANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock.
